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Eye (1994) 8, 414-418 © 1994 Royal College of Ophthalmologists surgery to the care of their ophthalmologist/optician from whom the long-term outcome was requested and provided in 2 cases. Two patients had no more than 3 months of follow-up and were excluded from the study. Three patients had no previous retinal surgery and were also excluded from the study. Tw enty-seven patients who had undergone previous retinal surgery remained in the study. One of these patients had repeat cyclocryotherapy per formed, bringing the total number of procedures to 28, The length of follow-up after cyclocryotherapy was between 6 months and 5 years.
The patients were between 18 and 69 years old (average age 44.5 years). Nine were female, 18 were male. The original retinal problems are summarised in Table 1 . All were retinal detachments, of which 17 were associated with congenital eye problems, giant tears, proliferative diabetic retinopathy, trauma or retinal schisis. The original surgery had been performed 1-12 years (average 4.5 years) earlier and included vitrectomy with injection of intravitreal silicone oil in 26 patients and scleral buckling without vitrectomy in 1 patient. Either 1000 or 5000 cs silicone oil was used, The total number of retinal oper ations undergone by each patient ranged from 1 to 5 (aver age 2,2). Silicone oil was removed in 7 (27%) patients after 4-36 months (average 18 months). In another 4 (15%) patients silicone oil was removed after 1-9 years, but had to be replaced after redetachment of the retina 2 weeks to 9 years after removal of the oiL Silicone oil was not removed in 15 (58%) patients. Twenty-two (79%) patients were aphakic. Seven (26%) patients had a history of glaucoma before silicone oil injection or before retinal surgery. All patients had chronic glaucoma with no pupil block at the time of surgery. The pre-operative intraocular pressure ranged from 20 to 68 mmHg (average 37.2 mmHg). The pre-operative vision was between 6/18 and perception of light (Table II) . The indication for surgery was sight preservation in 22 eyes, failed medical treatment in 26 eyes, intolerance to acetazolamide in 3 eyes and pain relief in 4 eyes. Pre operatively the patients had been on 1-4 (average 2.6) pressure-lowering drugs which included beta blockers, pilocarpine, propine or adrenaline, phospho line iodine and acetazolamide (Table III) .
Cyclocryotherapy was performed by four surgeons using a standard technique with the patient under general anaes thesia. The retinal probe of the Keeler-Amoils Cryo Unit ACU Mk 2 was placed 3-4 mm behind the limbus so that the edge of the iceball terminated at the comeoscleral junction. The cryopexy was applied until the iceball reached its maxi mum diameter, which took about 45 seconds. The first 3 patients were treated with 1800 cyclocryotherapy; in the other 25 procedures all 3600 of the ciliary body were treated. The number of applications of cryopexy ranged from 7 to 13 (average 11-12). Post-operatively, topical corticosteroids and cycloplegics were applied.
The intraocular pressure and visual acuity were recorded at 1, 3, 6 and 12 months post-operatively. Visual acuity was recorded on a Snellen chart. Patients with vision poorer than 6/60 were recorded as having 1-5/60 vision, counting fingers, hand movements, perception of light or no perception of light. Visual improvement or deterioration was recorded on the basis of a change of 2 lines of Snellen acuity or a change from one of the pre viously mentioned categories to another. The presence of 415 ocular pain, uveitis, cataract and ocular hypotony or phthi sis bulbi were recorded. We defined ocular hypotony as an intraocular pressure of below 6 mmHg and phthisis bulbi as a shrunken eye with no perception of light.
RESULTS
The post-operative intraocular pressures are summarised in Table IV . The average intraocular pressure 1 month post-operatively was 2l.7 mmHg (range 10-32 mmHg), an average fall of 15 mmHg. After 3 months the average intraocular pressure remained stable at from 11.0 to 13.3 mmHg (range 0-32 mmHg), with an average fall of 24-26 mmHg. More than 85% of patients had intraocular pres sures of less than 21 mmHg after 3 months, and this was maintained after 1 year. This excludes 1 eye which required a Molteno implant for control of continued raised intraocular pressure (36 mmHg) 6 weeks after cyclo cryotherapy; this reduced the pressure to 14-20 mmHg.
The pre-and post-operative intraocular pressures at the latest follow-up (between 6 months to 5 years) are sum marised in Fig. 1 . In 6 eyes (21.4%), cyclocryotherapy failed to bring the intraocular pressure below 21 mmHg. Four of these were treated with topical beta blockers and 2 underwent repeat cyclocryotherapy. Of the 4 eyes on topical beta blockers, 3 had intraocular pressures above 21 mmHg despite medi cation and 1 of these underwent repeat cyclocryotherapy 3 years after the first procedure. One eye had a Molteno tube implanted 6 weeks after cyclocryotherapy for an intraocular pressure of 36 mmHg. The average number of cryopexy applications in the eyes with intraocular pres sures greater than 21 mmHg was 9-10 as opposed to 11-12 in the patients who had pressures of less than 21 mmHg.
Between 22% and 28% of eyes were hypotonic with intraocular pressures of less than 6 mmHg after 3 months to 1 year. In 2 of these 7 eyes the indication for surgery had been pain relief. The average number of cryopexy appli cations in the hypotonic eyes was 11-12 -no different from the average number of cryopexy applications in patients with pressures of 6 mmHg or greater. . Table V summarises the post-operative visual results. At 6 months after treatment 19 eyes (68%) had retained the same vision or improved, and 9 (32%) patients experi enced a deterioration of vision. After I year. 36% of the eyes experienced a reduction in vision. The eyes which became hypotonic were associated with a deterioration of vision (57%) more frequently than those with intraocular pressures 6 mmHg or greater (24%) ( Table VI) . The odds of a hypotonic eye losing vision were 4.27 times greater than for an eye which was not hypotonic. Thirty-six per cent of patients lost vision after 1 year ( Table V) . The degree of visual loss. when present, was confined to a fall from one category to the next, the cate gories being defined in Table II -r----------------------- 
